Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Vara logo — Making data-driven breast cancer screening accessible to eve...

Vara

Making data-driven breast cancer screening accessible to everyone; deeptech with a measurable impact backed by evidence.

Founded 2018 Germany Berlin, Germany 56 employees Total: $19.90M AI, Health Care +1

General Information

Company Name Vara
Founded Year 2018
Location Germany Berlin, Germany
Founders / Decision Makers
Team member
Employees 56
Industries AI, Health Care, Machine Learning
Business Model B2B, SaaS, B2G
Revenue Model Subscription, Usage Based, Tiered Pricing
Offices as of Aug 2026
Berlin, Germany
Social

BounceWatch is an independent company data service, not affiliated with Vara. To contact Vara, visit vara.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Vara compare?

A PDF of Vara and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Vara soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Vara

Vara, founded in 2018, is a pioneering company based in Germany that leverages AI and Machine Learning to enhance the accessibility and effectiveness of breast cancer screening. Their mission, encapsulated by their slogan, "Making data-driven breast cancer screening accessible to everyone; deeptech with a measurable impact backed by evidence," underscores their commitment to universal health care improvements.

The company's innovative software, developed with screening radiologists, reduces human subjectivity in mammography readings, making screenings not only more accurate but also less labor-intensive for physicians. By democratizing access to early screening worldwide, Vara aims to have a significant, evidence-backed impact on global health.

In June 2025, Vara received early VC investment from JR Investment, indicating confidence in their potential for impactful disruption in the healthcare sector. Their approach positions them uniquely at the intersection of AI and Health Care, promising substantial benefits for early cancer detection worldwide.

Business keywords: AI-powered software, breast cancer screening, radiology enhancement, clinical evidence, medical imaging innovation, deeptech solutions, early detection, democratized healthcare, radiologist assistance, innovation in medical diagnostics, partnership development, global healthcare access

Services & Products

AI-assisted triage
Automated reporting
Safety Net for missed findings
Configurable AI thresholds
Continuous monitoring
Independent reader capabilities

Target Customers

Radiologists Screening Programmes Policymakers Health Authorities Distribution Partners Hospital IT

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Early VC Undisclosed 1
JR Investment
01 Jun 2025
Early VC $8.90M 9
EQT Ventures IBB Ventures VI Partners
EQT Ventures, IBB Ventures +7
01 Oct 2024
Series A Undisclosed 6
EQT Ventures VI Partners Soleria Capital
EQT Ventures, VI Partners +4
01 Feb 2024
Series A €4.50M 5
VI Partners Merantix Think.Health Ventures
VI Partners, Merantix +3
01 Oct 2022
Seed $6.50M 5
Omers Ventures Merantix Soleria Capital
Omers Ventures, Merantix +3
01 Jun 2020

Vara Alternatives & Competitors

View All Alternatives
Vara vs
Lunit Cancer Screening
Lunit Cancer Screening United States

Lunit is a public company that develops medical AI software that helps conquer cancer globally.

Post-IPO Debt
320 employees
AI, Analytics
Compare Vara vs Lunit Cancer Screening
Vara vs
b-rayZ
b-rayZ Switzerland

Empower Mammography through Artificial Intelligence

Series A
20 employees
AI, Analytics
Compare Vara vs b-rayZ
Vara vs
MICA AI Medical
MICA AI Medical Israel

Mammography Image Comparison Analysis - Improving Early Detection Of Breast Cancer

Seed
9 employees
AI, Health Care
Also compare with: Vara vs Ezra Ezra Vara vs Floy GmbH Floy GmbH View all alternatives

FAQ About Vara

Making data-driven breast cancer screening accessible to everyone; deeptech with a measurable impact backed by evidence.
Vara was founded in 2018.
Vara is headquartered in Berlin, Germany.
Vara operates in AI, Health Care and Machine Learning. Its work centres on AI-powered software, breast cancer screening, radiology enhancement and clinical evidence. Its customers include Radiologists, Screening Programmes and Policymakers.
Vara has a B2B, SaaS and B2G business model. Its revenue comes from Subscription, Usage Based and Tiered Pricing.
Vara has approximately 56 employees.
Vara has completed 5 funding rounds, raising a total of $19.90M.
Vara offers: AI-assisted triage, Automated reporting, Safety Net for missed findings, Configurable AI thresholds, Continuous monitoring, Independent reader capabilities.
Top alternatives and competitors to Vara include Lunit Cancer Screening, b-rayZ, MICA AI Medical, Ezra, Kheiron Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Vara and Lunit Cancer Screening are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Vara, https://bouncewatch.com/company/vara-1, updated 18 August 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout